GO:0005980 glycogen catabolic process: Glycogenolysis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005980 (glycogen catabolic process, also called glycogenolysis) describes the chemical reactions and pathways that break down glycogen, a polydisperse, highly branched glucan of D-glucose residues, into glucose-1-phosphate and free glucose.
• The process is executed by glycogen phosphorylase (PYGM in muscle, PYGL in liver, PYGB in brain), the debranching enzyme AGL, and downstream phosphoglucomutase and glucose-6-phosphatase activities.
• Glycogenolysis is dynamically regulated by phosphorylation cascades, allosteric ligands, and substrate compartmentalization rather than being a simple linear degradation route.
• In the brain, astrocytic glycogenolysis supplies lactate and glucose intermediates that support neuronal energetics during activation, and its dysregulation is linked to metabolic stress.
• Loss or gain of glycogenolytic enzymes is implicated in myocardial infarction, metabolic disease, and immune memory T-cell function, making these enzymes attractive experimental targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of glycogen catabolic process genes in disease-relevant cell backgrounds.
Description
Glycogen catabolic process (GO:0005980), commonly called glycogenolysis, is the set of biochemical reactions that degrade glycogen, a polydisperse and highly branched glucan composed of D-glucose residues, into usable glucose derivatives. It is a core energy-mobilization pathway that allows cells to release glucose-1-phosphate from stored polysaccharide and, depending on tissue, to generate free glucose for export or intracellular use. Because glycogen is a large, branched polymer, its breakdown requires coordinated activities of glycogen phosphorylase, debranching enzyme, and phosphoglucomutase, and the pathway is tightly coupled to the structural dynamics of the glycogen granule. Researchers study GO:0005980 because it sits at the intersection of carbohydrate metabolism, cellular energetics, and disease. In muscle and heart, glycogenolysis supports contraction and ischemic resilience, and PYGM has been shown to protect against myocardial infarction by enhancing glycogenolysis and autophagic flux. In the brain, astrocytic glycogenolysis contributes to energetics during activation and is mechanistically distinct from muscle and liver regulation. In the immune system, glucose-1-phosphate produced by glycogen breakdown promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells, linking glycogen catabolism to immune memory. This article integrates the QuickGO definition of GO:0005980 with verified PubMed literature to summarize the mechanism, key genes, regulation, disease relevance, and experimental models used to interrogate glycogen catabolic process. It is written for researchers who need a precise, citable overview for grant writing, target validation, and CRISPR experimental design.
glycogen catabolic process At A Glance
| GO ID | GO:0005980 |
|---|---|
| GO term | glycogen catabolic process |
| Ontology | biological_process |
| Synonym | glycogen breakdown; glycogen catabolism; glycogen degradation; glycogenolysis |
| Major function | Breakdown of glycogen into glucose-1-phosphate and free glucose for cellular energy and glucose homeostasis |
| Key enzymes | Glycogen phosphorylase (PYGM, PYGL, PYGB), debranching enzyme AGL, phosphoglucomutase PGM1, glucose-6-phosphatase G6PC |
| Subcellular context | Cytosol, associated with glycogen granules and metabolic compartmentalization |
| Regulatory mode | Phosphorylation cascades, allosteric regulation, and substrate compartmentalization |
| Representative tissues | Skeletal muscle, liver, brain astrocytes, heart, immune cells |
What Is GO:0005980?
GO:0005980 glycogen catabolic process is defined by QuickGO as the chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues. In practical terms, it covers the enzymatic steps that convert glycogen into glucose-1-phosphate and free glucose, including phosphorolysis by glycogen phosphorylase, removal of branch points by debranching enzyme, and subsequent interconversion of glucose-1-phosphate by phosphoglucomutase. The term is synonymous with glycogen breakdown, glycogen catabolism, glycogen degradation, and glycogenolysis.
Why Is glycogen catabolic process Important in Cell Biology?
Glycogen catabolic process is essential because it mobilizes the largest rapidly available carbohydrate store in cells and thereby sustains ATP production, glucose homeostasis, and metabolic signaling. Its dysregulation or genetic loss contributes to ischemic injury, metabolic disease, and altered immune cell function, and its enzymes are tractable targets for CRISPR-based causal studies.
• Provides glucose-1-phosphate and free glucose during periods of high energy demand or limited external glucose supply.
• Supports cardiac protection in myocardial infarction through PYGM-dependent glycogenolysis and autophagic flux.
• Contributes to astrocytic energetics and neuronal support during brain activation.
• Links glycogen metabolism to the pentose phosphate pathway in CD8+ memory T cells, influencing immune memory.
• Is dynamically regulated at the level of glycogen granule structure and enzyme phosphorylation.
• Serves as a model pathway for studying compartmentalized metabolism and metabolic channeling.
• Provides disease-relevant targets for metabolic, cardiovascular, and neuro-metabolic research.
• Enables CRISPR screens and functional genomics of carbohydrate metabolism genes.
• Informs studies of glucose metabolism in specialized tissues such as enamel-forming ameloblasts.
• Connects to systemic glucose regulation through liver glycogenolysis and gluconeogenesis.
What Happens During glycogen catabolic process?
Initiation by glycogen phosphorylase
In simple terms: The first step cuts glucose units off the outer branches of glycogen.
Glycogen catabolic process begins when glycogen phosphorylase cleaves alpha-1,4-glycosidic bonds at the non-reducing ends of glycogen, releasing glucose-1-phosphate. This phosphorolytic cleavage preserves energy in the glycosidic bond and is the rate-limiting entry step of glycogenolysis. In muscle, the PYGM isoform is a major phosphorylase, and its activity is required for efficient glycogen breakdown during stress such as myocardial infarction.
Debranching of limit dextrins
In simple terms: A second enzyme removes the branch points that phosphorylase cannot cut.
Because glycogen phosphorylase cannot cleave alpha-1,6 branch points, the debranching enzyme AGL transfers short oligosaccharide chains and hydrolyzes the branch linkage, generating linear dextrins that phosphorylase can further degrade. This step is essential for complete glycogen breakdown and for producing glucose-1-phosphate from the branched polymer.
Conversion of glucose-1-phosphate
In simple terms: The product of glycogen breakdown is converted into a form the cell can use.
Glucose-1-phosphate generated by phosphorylase and debranching enzyme is converted by phosphoglucomutase to glucose-6-phosphate, which can enter glycolysis or be dephosphorylated by glucose-6-phosphatase in liver and kidney to release free glucose. This interconversion links glycogen catabolic process to glycolysis, the pentose phosphate pathway, and systemic glucose homeostasis.
Compartmentalization with metabolic pathways
In simple terms: Glycogen breakdown is spatially organized with other metabolic routes.
Recent work shows that glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells, indicating that glycogen catabolic process is not a freely diffusing reaction but is organized into metabolic compartments. The dynamic life of the glycogen granule further supports the view that glycogenolysis is coupled to granule structure and protein composition.
Tissue-specific regulation of glycogenolysis
In simple terms: Different tissues control glycogen breakdown in different ways.
The regulation of glycogenolysis in the brain differs from that in muscle and liver, with astrocytic glycogenolysis contributing to energetics during brain activation. In liver, glycogenolysis is integrated with gluconeogenesis and insulin signaling. These tissue-specific mechanisms determine whether glycogen-derived carbon is oxidized locally, exported as glucose, or used for biosynthetic pathways.
Key Genes Involved in GO:0005980 glycogen catabolic process
The following genes and proteins are central to glycogen catabolic process and are commonly studied using CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PYGM | Muscle glycogen phosphorylase; initiates glycogenolysis | Cardiac protection in myocardial infarction; muscle metabolism |
| PYGL | Liver glycogen phosphorylase; releases glucose for systemic use | Hepatic glucose homeostasis and gluconeogenesis |
| PYGB | Brain-type glycogen phosphorylase | Astrocytic and neuronal energetics |
| AGL | Debranching enzyme; removes alpha-1,6 branch points | Complete glycogen degradation; glycogen storage disease models |
| PGM1 | Phosphoglucomutase; converts glucose-1-phosphate to glucose-6-phosphate | Links glycogenolysis to glycolysis and pentose phosphate pathway |
| G6PC | Glucose-6-phosphatase; releases free glucose in liver/kidney | Systemic glucose homeostasis |
| PPP1R3A | Protein phosphatase 1 regulatory subunit; regulates glycogen metabolism | Phosphorylation control of glycogen enzymes |
| PHKA1 | Phosphorylase kinase alpha subunit; activates phosphorylase | Signal transduction to glycogenolysis |
| PHKB | Phosphorylase kinase beta subunit | Regulation of glycogen catabolic process |
| CALM1 | Calmodulin; calcium-dependent regulation of phosphorylase kinase | Calcium signaling to glycogenolysis |
| PRKAA1 | AMPK catalytic subunit; energy-sensing regulator | Metabolic stress and glycogen metabolism |
| PRKAA2 | AMPK catalytic subunit | Energy homeostasis and glycogenolysis |
| SLC2A4 | GLUT4 glucose transporter; couples transport to metabolism | Glucose uptake and glycogen turnover |
| GYS1 | Glycogen synthase; opposing anabolic enzyme | Balance between synthesis and catabolism |
| GYS2 | Liver glycogen synthase | Hepatic glycogen metabolism |
| STBD1 | Starch-binding domain protein 1; glycogen granule protein | Glycogen granule dynamics |
| PPP1CA | Protein phosphatase 1 catalytic subunit | Dephosphorylation and enzyme regulation |
| GAA | Lysosomal acid alpha-glucosidase; degrades glycogen in lysosomes | Autophagic and lysosomal glycogen breakdown |
How Is glycogen catabolic process Regulated?
Glycogen catabolic process is regulated at multiple levels. Covalent phosphorylation by phosphorylase kinase activates glycogen phosphorylase, while protein phosphatase 1 reverses this activation, allowing rapid switching between glycogen synthesis and breakdown. Allosteric effectors such as AMP, ATP, and glucose-6-phosphate tune enzyme activity to the cellular energy state. In the brain, astrocytic glycogenolysis is regulated by neurotransmitters and metabolic signals that differ from peripheral tissues. Insulin and glucagon signaling integrate liver glycogenolysis with gluconeogenesis and systemic glucose homeostasis. More recently, compartmentalization of glycogen with the pentose phosphate pathway has emerged as a regulatory layer in immune cells.
glycogen catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PYGM | Myocardial infarction; cardiac energetics | PYGM knockout and overexpression in cardiomyocytes |
| PYGL | Hepatic glucose homeostasis; metabolic disease | PYGL knockout in hepatocyte-like cells |
| AGL | Glycogen storage disease; debranching deficiency | AGL knockout in muscle or liver cell models |
| PGM1 | Metabolic compartmentalization; immune memory | PGM1 knockout in CD8+ memory T cells |
| PYGB | Brain energetics; neuro-metabolic stress | PYGB knockout in astrocytes |
Cardiovascular disease and myocardial infarction
PYGM protects against myocardial infarction by enhancing glycogenolysis and facilitating autophagic flux, indicating that glycogen catabolic process is cardioprotective under ischemic stress. Loss of PYGM function may impair energy supply and autophagic clearance, worsening injury.
Metabolic and hepatic disorders
Liver glycogenolysis is integrated with gluconeogenesis and insulin signaling, and its dysregulation contributes to impaired glucose homeostasis. Enzymes such as PYGL and G6PC are directly relevant to hepatic glucose output and metabolic disease models.
Neuro-metabolic and brain energetics
Astrocytic glycogenolysis supports brain energetics during activation, and its mechanisms and functions are distinct from peripheral glycogenolysis. Disruption of brain glycogen catabolic process may compromise neuronal support under high demand.
Immune memory and T-cell metabolism
Glucose-1-phosphate from glycogen breakdown promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells, linking glycogen catabolic process to immune memory and redox metabolism.
From glycogen catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PYGM required for cardioprotection after ischemia? | PYGM knockout and overexpression in cardiomyocytes |
| Does glycogenolysis control T-cell memory metabolism? | PGM1 or PYGL knockout in CD8+ memory T cells |
| How does debranching enzyme loss affect glycogen structure? | AGL knockout with glycogen imaging |
| What is the role of brain-type phosphorylase in astrocyte energetics? | PYGB knockout in astrocytes |
| How does liver glycogenolysis integrate with gluconeogenesis? | PYGL knockout in hepatocytes |
| Can point mutations in phosphorylase alter activity? | Point-mutation knock-in of PYGM or PYGL |
How to Study the glycogen catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isotope tracing | Flux of glycogen-derived carbon | Compartmentalization with pentose phosphate pathway |
| Glycogen imaging | Granule structure and localization | Dynamic life of glycogen granule |
| Phosphorylase activity assay | Enzyme catalytic activity | PYGM/PYGL function after CRISPR editing |
| RNA-seq | Transcriptional changes | Pathway gene expression after knockout |
| Proteomics | Protein abundance and interactions | Glycogen granule composition |
| Metabolomics | Glucose-1-phosphate and intermediates | Metabolic impact of glycogenolysis |
| Autophagic flux assay | Autophagic degradation | PYGM-dependent cardioprotection |
Metabolic flux and isotope tracing
Isotope tracing and metabolic flux analysis can quantify glycogen-derived carbon entering glycolysis and the pentose phosphate pathway, revealing compartmentalization of glycogen catabolic process.
Glycogen imaging and granule analysis
Imaging of glycogen granules and their protein composition provides insight into the dynamic life of the glycogen granule and how catabolism is spatially organized.
Enzyme activity assays
Glycogen phosphorylase and debranching enzyme activities can be measured in lysates or live cells to assess the functional impact of CRISPR edits on glycogen catabolic process.
Transcriptomics and proteomics
RNA-seq and proteomics can identify changes in glycogenolytic enzyme expression and interacting proteins after genetic perturbation, linking genotype to pathway output.
How CRISPR Can Be Used to Study GO:0005980 glycogen catabolic process
Knockout
CRISPR knockout of PYGM, PYGL, PYGB, AGL, or PGM1 can abolish specific steps of glycogen catabolic process, enabling causal tests of enzyme requirement in disease models such as myocardial infarction and T-cell memory.
Point Mutation
Point-mutation knock-in can model patient-derived missense variants in glycogenolytic enzymes, allowing assessment of catalytic activity, allosteric regulation, and phosphorylation sites without confounding expression changes.
Knock-in
Knock-in of tagged or reporter alleles at endogenous loci enables real-time tracking of glycogen phosphorylase or debranching enzyme localization and dynamics during glycogen catabolic process.
Overexpression
Overexpression of PYGM or other glycogenolytic enzymes can test sufficiency for cardioprotection, autophagic flux enhancement, or metabolic reprogramming in cell and animal models.
How EDITGENE Supports glycogen catabolic process Research
Researchers studying glycogen catabolic process-related genes often need to determine whether a candidate gene is causally involved in glycogen breakdown, metabolic compartmentalization, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of glycogenolytic pathway components.
Contact EDITGENE today to design your custom CRISPR model for glycogen catabolic process research.
Frequently Asked Questions About glycogen catabolic process
What is glycogen catabolic process?
Glycogen catabolic process (GO:0005980), also called glycogenolysis, is the breakdown of glycogen into glucose-1-phosphate and free glucose through enzymes such as glycogen phosphorylase and debranching enzyme.
What genes are involved in glycogen catabolic process?
Key genes include PYGM, PYGL, PYGB, AGL, PGM1, and G6PC, which together mediate phosphorolysis, debranching, and glucose phosphate interconversion.
What is the difference between glycogenolysis and glycogen catabolic process?
They are synonyms; glycogenolysis is the common name for GO:0005980, the biological process of glycogen breakdown.
How is glycogen catabolic process regulated?
It is regulated by phosphorylation cascades, allosteric effectors, and compartmentalization with pathways such as the pentose phosphate pathway.
Why is glycogen catabolic process important in the brain?
Astrocytic glycogenolysis supports brain energetics during activation and has distinct regulatory mechanisms compared with peripheral tissues.
What diseases are linked to glycogen catabolic process?
It is linked to myocardial infarction, hepatic metabolic disorders, neuro-metabolic stress, and immune memory metabolism.
How can CRISPR be used to study glycogen catabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression can perturb glycogenolytic genes to test causality in disease models.
What methods measure glycogen catabolic process?
Isotope tracing, glycogen imaging, enzyme activity assays, RNA-seq, proteomics, and metabolomics are commonly used.
What is the role of PYGM in glycogen catabolic process?
PYGM is the muscle glycogen phosphorylase that initiates glycogen breakdown and protects against myocardial infarction by enhancing glycogenolysis and autophagic flux.
How does glycogen catabolic process connect to the pentose phosphate pathway?
Glucose-1-phosphate produced by glycogen breakdown promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8+ memory T cells.
Conclusion
Glycogen catabolic process (GO:0005980) is a central metabolic pathway that mobilizes glycogen stores into glucose-1-phosphate and free glucose through the coordinated action of glycogen phosphorylase, debranching enzyme, and phosphoglucomutase. Its regulation is tissue-specific and integrated with energy sensing, compartmentalization, and systemic glucose homeostasis. Dysregulation of glycogenolysis contributes to cardiovascular, hepatic, neuro-metabolic, and immune phenotypes, making its enzymes important experimental targets. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide causal tools to dissect these mechanisms and to validate therapeutic hypotheses in disease-relevant cell backgrounds.
References
- 1. Hatting M et al.. 2018. Insulin regulation of gluconeogenesis.. Ann N Y Acad Sci 1411(1):21-35 PMID: 28868790
- 2. Gan J et al.. 2025. PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.. Circulation 152(16):1146-1165 PMID: 40988610
- 3. Zhou Y et al.. 2025. Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8(+) memory T cells.. Mol Cell 85(13):2535-2549.e10 PMID: 40499549
- 4. Prats C et al.. 2018. The dynamic life of the glycogen granule.. J Biol Chem 293(19):7089-7098 PMID: 29483195
- 5. Nadeau OW et al.. 2018. The regulation of glycogenolysis in the brain.. J Biol Chem 293(19):7099-7107 PMID: 29483194
- 6. Ida-Yonemochi H. 2025. Role of glucose metabolism in amelogenesis.. J Oral Biosci 67(2):100667 PMID: 40306383
- 7. Dienel GA et al.. 2015. Contributions of glycogen to astrocytic energetics during brain activation.. Metab Brain Dis 30(1):281-98 PMID: 24515302
- 8. Hertz L et al.. 2015. Astrocytic glycogenolysis: mechanisms and functions.. Metab Brain Dis 30(1):317-33 PMID: 24744118
